VRVijay Kumar Rekulapally

Vijay Kumar Rekulapally

*This is an algorithmically generated author record based on publicly available information.

Vijay Kumar Rekulapally has a total of 11 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Green Liquid Chromatography Method for the Determination of Related Substances Present in Olopatadine HCl Nasal Spray Formulation, Robustness by Design Expert

    by Leela Prasad Kowtharapu, Naresh Kumar Katari, Christian A Sandoval, Siva Krishna Muchakayala, Vijay Kumar Rekulapally

    Background: Dual therapeutic nature drug mast cell stabilizer and histamine receptor antagonist olopatadine hydrochloride (OPT) nasal spray does not have an official monograph, and no literature is available. Eye drops formulation had the official monograph for impurities, but the determination was done in two methods. Objective: A simple and effective green liquid chromatography method to develop and validate for the related substances of OPT nasal spray formulation. Method: A 25 min gradient method was employed to separate impurities and OPT with a 1.0 mL/min flow rate using a Boston green C8 (150 mm × 4.6 mm, 5 µm) HPLC column. The set wavelength and column oven temperatures were 299 nm and 30°C, respectively. pH 3.5 phosphate buffer–acetonitrile in the ratio of (70:30, v/v) as mobile phase A and (50:50, v/v) ratio as mobile phase B. A Quality by Design (QbD) based Design of Experiments (DoE) was employed to evaluate the robustness characteristics of the analytical method validation. Results: The obtained RSD from the precision and intermediate precision was 0.4 to 4.1%. The % recovery of the impurities from LOQ to 150% of specification level was 87.5 to 110.3%. The linear regression curves for the impurities with a correlation coefficient of >0.999 indicate that all peak responses are linear with the concentration. The sample and standard solutions were stable for 24 h at benchtop and refrigerator conditions. Conclusions: All the critical peaks were well separated from the forced degradation studies’ diluent, placebo, and generated degradation peaks. The method validation data and QbD based robustness study results indicate that the developed impurities method fits the routine quality control laboratory use. National Environmental Index (NMEI), Green Analytical Procedure Index (GAPI), Analytical Eco-scale and Analytical Greenness (AGREE) tools expressed the method’s greenness. Highlights: The proposed method is QbD utilized and green chemistry assessed impurities determination method for OPT in nasal spray formulation.


  • Unique green chromatography method for the determination of serotonin receptor antagonist (Ondansetron hydrochloride) related substances in a liquid formulation, robustness by quality by design‐based design of experiments approach

    by Leela Prasad Kowtharapu, Naresh Kumar Katari, Christian A Sandoval, Siva Krishna Muchakayala, Vijay Kumar Rekulapally

    Serotonin receptor antagonist drug Ondansetron hydrochloride injectable formulation containing all related substances was identified and quantified by a single, simple, sensitive, eco‐friendly, and green high‐performance liquid chromatography method. The disseverment of all impurities was achieved with the Discovery Cyano (250 × 4.6) mm, 5 μm column. The gradient program was composed of pH 5.7 phosphate buffer as mobile phase A and acetonitrile as mobile phase B. The flow rate, column compartment temperature, and detection wavelengths were 0.9 mL/min, 30°C, and 216 nm, respectively. The method was validated as per current regulatory guidelines. The obtained %relative standard deviation for the precision results was between 0.55 and 2.72% for all impurities. The correlation coefficient values from the linearity experiment for impurities and analyte were more than 0.995. The accuracy results were obtained between 88.4 and 113.0% for all impurities. Both sample and standard solutions showed 24 h stability at benchtop and refrigerator conditions. All impurities and analytes met the specificity and mass balance for all forced degradation conditions. Quality‐by‐design‐based design of experiments was utilized to establish the method's robustness. Method greenness was assessed by using the current advanced tool green analytical procedure index, National Environmental Methods Index, and analytical eco‐scale.


  • A validated stability‐indicating reversed‐phase‐HPLC method for dipyridamole in the presence of degradation products and its process‐related impurities in pharmaceutical dosage forms

    by Ravindra Mallavarapu, Naresh Kumar Katari, Thirupathi Dongala, Vijay Kumar Rekulapally, Vishnu Murthy Marisetti, Govind Vyas

    In this study, we developed and validated a method to determine dipyridamole‐related impurities in pharmaceutical dosage forms using the reversed‐phase‐HPLC technique. All impurities were separated on a YMC pack C8 (150 mm × 4.6 mm, 3.0 μm) analytical column using a suitable mobile phase. Mobile phase A was 10 mM concentration of phosphate buffer (pH adjusted to 4.7 by adding diluted orthophosphoric acid) and mobile phase B was buffer:acetonitrile:methanol (at the ratio of 30:40:30 v/v). The optimized chromatographic conditions used in the experiment were as follows: flow rate, 1.0 mL/min; injection volume, 10 μL and column temperature, 35°C. Chromatographic detection was performed at 295 nm. The stressed samples were analyzed for degradation under acidic, basic, peroxide, water hydrolysis, and physical degradation conditions. The proposed method was validated according to International Conference on Harmonization (ICH) guidelines, and found to be specific, linear, accurate and have a robust stability‐indicating nature. The method showed excellent linearity from limit of quantification (LOQ) to 150% level of concentrations for all impurities. The correlation coefficient (r2) for all impurities was between 0.995 and 0.999. The recovery study was performed from LOQ to 150% level concentrations, with mean recovery values between 92.9% and 103.2%, respectively. The developed method can be used to determine dipyridamole and its relative impurities. The degradation and validated study results indicate its stability‐indicating nature. Therefore, the method can be used in pharmaceutical research and development and quality control departments.


  • Open Access

    A QbD and Green Analytical Chromatography Technique for the Determination of Active Pharmaceutical Ingredient, Preservative and Antioxidant Contents in Lincosamide Antibiotic Injectable Formulation

    by Mr.LEela Prasad Kowtharapu, Naresh Kumar Katari, Dr.CHristian A. Sandoval, Mr.SIva Krishna Muchakayala, Dr.RAjyalakshmi Ch, Vijay Kumar Rekulapally

    A lincosamide antibiotic injectable formulation contains clindamycin phosphate (CMN), benzyl alcohol (BAL), and Ethylenediaminetetraacetic acid (EDTA), all the contents were qualitatively and quantitatively determined by a single green liquid chromatography method. The three components were separated with Phenomenex prodigy C8 (250 mm x 4.6 mm, 5µm) HPLC column, flow rate 1.1 mL/min, injection volume 30 µL, and column temperature 35 °C. Lambda max 240 nm was set for the detection. 0.05M, pH 4.5 sodium acetate buffer with acetonitrile in the ratio of (80:20, v/v) were used. The method was validated as per ICH guidelines and proven that the method was specific, precise, accurate, and linear. Method robustness executed by utilizing quality by design experiment and concluded method is robust. Accuracy results were found 99.6 to 100.5 for CMN, 99.8 to 100.5 for BAL, and 99.2 to 100.1 for EDTA. Precision results were obtained % RSD 1.0% for CMN, 0.8% for BAL and 0.6% for EDTA. Correlation coefficient (r2) values obtained more than 0.999 for three components. Analytical solutions are stable for 48 hrs at benchtop and refrigerator conditions. Analytical method greenness was evaluated by utilizing the GAPI, NEMI, and analytical Eco-scale tools and confirmed the method is Eco-friendly.


  • Open Access

    A Novel, Rapid, and Validated Stability-Indicating UPLC Method for the Estimation of Drotaverine Hydrochloride and Ibuprofen Impurities in Oral Solid Dosage Form

    by Rekulapally Vijay Kumar

    A novel, stability-indicating, reversed-phase ultra-performance liquid chromatographic (RP-UPLC) method was developed for the determination of pure drotaverine hydrochloride and ibuprofen in the presence of their impurities and degradation products. The method was developed using a Waters UPLC BEH C18, 100 x 2.1 mm, 1.7 mu m column with a flow rate of 0.3 mL/min and detector wavelength at 210 nm. The mobile phase consisted of potassium dihydrogen orthophosphate buffer and acetonitrile. Drotaverine hydrochloride and ibuprofen were subjected to the stress conditions of oxidative, acid, base, photolytic, and thermal degradation. Degradation products resulting from the stress studies were well-resolved, thus confirming the test method as stability-indicating. Validation of the method was carried out as per International Conference on Harmonization guidelines.